GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Takara Bio Inc (TSE:4974) » Definitions » 3-Year Dividend Growth Rate

Takara Bio (TSE:4974) 3-Year Dividend Growth Rate : 73.80% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Takara Bio 3-Year Dividend Growth Rate?

Takara Bio's Dividends per Share for the three months ended in Dec. 2023 was 円0.00.

The historical rank and industry rank for Takara Bio's 3-Year Dividend Growth Rate or its related term are showing as below:

TSE:4974' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 14.5   Med: 44.2   Max: 73.8
Current: 73.8

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Takara Bio was 73.80% per year. The lowest was 14.50% per year. And the median was 44.20% per year.

TSE:4974's 3-Year Dividend Growth Rate is ranked better than
87.14% of 70 companies
in the Biotechnology industry
Industry Median: 14.15 vs TSE:4974: 73.80

During the past 12 months, Takara Bio's average Dividends Per Share Growth Rate was 27.30% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 73.80% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 57.70% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 44.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Takara Bio's Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.00. As of today, Takara Bio's Dividend Yield % is 1.56%.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Takara Bio Inc is 2.71, which seems too high.

Warning Sign:

Takara Bio Inc stock dividend yield is close to 2-year low.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Takara Bio's 3-Year Dividend Growth Rate

For the Biotechnology subindustry, Takara Bio's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Takara Bio's 3-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Takara Bio's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Takara Bio's 3-Year Dividend Growth Rate falls into.



Takara Bio 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Takara Bio  (TSE:4974) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Takara Bio's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0/ -7.21
=N/A

During the past 13 years, the highest Dividend Payout Ratio of Takara Bio was 2.71. The lowest was 0.09. And the median was 0.20.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Takara Bio Inc is 2.71, which seems too high.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Takara Bio Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
JPY 17.0000002024-03-282024-03-312024-06-24Cash Dividendsemi-annuallyJPY:JPY 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Takara Bio's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=17/1092.00
=1.56 %

Current Share Price is 円1092.00.
Takara Bio's Dividends per Share for the trailing twelve months (TTM) ended in Today is 円17.

During the past 13 years, the highest Dividend Yield of Takara Bio was 4.39%. The lowest was 0.03%. And the median was 0.26%.

Warning Sign:

Takara Bio Inc stock dividend yield is close to 2-year low.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Takara Bio 3-Year Dividend Growth Rate Related Terms>


Takara Bio (TSE:4974) Business Description

Industry
Traded in Other Exchanges
Address
Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058
Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.

Takara Bio (TSE:4974) Headlines

No Headlines